Notice of Postal Ballot - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclsoure Requirements), Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Limited has issued a Postal Ballot notice seeking shareholder approval to reclassify four members of the promoter/promoter group (Mr. Sai Sudhakar Vankineni, Ms. Snigdha Vankineni, Mr. Sumanth Simha Vankineni, and Mrs. Jhansi Rani Vankineni) as public shareholders. Together, these four outgoing promoters hold 9,42,700 equity shares, representing just 2.55% of the company's paid-up capital. BSE had already granted its no-objection for this reclassification on October 16, 2025, and the Board approved the move on August 25, 2025. E-voting will run from November 12, 2025 (9:00 AM) to December 11, 2025 (5:00 PM), with results to be announced within two working days after voting closes. The resolution will be deemed passed on December 11, 2025, if approved by the requisite majority as an Ordinary Resolution.
The reclassification involves only 2.55% of shareholding and is largely a procedural change with no change in actual ownership or control, so the impact on shareholders and stock price is expected to be minimal to neutral. Public shareholding will increase marginally, helping the company maintain compliance with minimum public shareholding norms.